| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.14e-06 | 9 | 198 | 4 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.55e-05 | 16 | 198 | 4 | GO:0008242 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.88e-05 | 6 | 198 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.88e-05 | 6 | 198 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 4.01e-05 | 20 | 198 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 5.18e-05 | 8 | 198 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | calcium ion binding | CDH26 ITPR1 DST HMCN2 TCHHL1 RASGRP3 BAIAP3 DSG2 ADAMTS13 CLSTN1 RASGRP1 MCTP1 MACF1 SDF4 ADGRE5 PRKCSH EML1 MCTP2 CDH3 PCDHGC3 | 5.84e-05 | 749 | 198 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.49e-04 | 11 | 198 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 2.55e-04 | 13 | 198 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | glucokinase activity | 9.59e-04 | 5 | 198 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 9.59e-04 | 5 | 198 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 9.59e-04 | 5 | 198 | 2 | GO:0008865 | |
| GeneOntologyBiologicalProcess | cell junction organization | LGMN CDH26 MAP1B SPTB DAB1 DST HMCN2 SRGAP3 DLG1 DLG4 SHANK1 SEMA3F ANK3 DSG2 NBEA CAV1 CLSTN1 SPTBN4 TENM4 PAK3 MACF1 SDF4 ADGRE5 IGSF9B FAM9B PARD3 CDH3 PCDHGC3 | 1.52e-07 | 974 | 195 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.56e-06 | 10 | 195 | 4 | GO:1901750 | |
| GeneOntologyBiologicalProcess | synapse organization | LGMN MAP1B SPTB DAB1 HMCN2 SRGAP3 DLG1 DLG4 SHANK1 SEMA3F ANK3 NBEA CLSTN1 SPTBN4 TENM4 PAK3 SDF4 ADGRE5 IGSF9B FAM9B PCDHGC3 | 2.29e-06 | 685 | 195 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.43e-06 | 11 | 195 | 4 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 3.61e-06 | 12 | 195 | 4 | GO:1901748 | |
| GeneOntologyBiologicalProcess | spermatogenesis | SPATA31A7 ACRV1 UTP14A MAST2 SPATA31A6 GGT1 GGT3P CFAP54 ZSCAN2 HERC2 TARBP2 SPATA31A3 SPATA31A5 GGT2P ZFX IGF2R PAFAH1B3 SSH2 FAM9B TDRP | 2.73e-05 | 744 | 195 | 20 | GO:0007283 |
| GeneOntologyBiologicalProcess | male gamete generation | SPATA31A7 ACRV1 UTP14A MAST2 SPATA31A6 GGT1 GGT3P CFAP54 ZSCAN2 HERC2 TARBP2 SPATA31A3 SPATA31A5 GGT2P ZFX IGF2R PAFAH1B3 SSH2 FAM9B TDRP | 3.82e-05 | 762 | 195 | 20 | GO:0048232 |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 4.50e-05 | 8 | 195 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 4.96e-05 | 22 | 195 | 4 | GO:0019370 | |
| GeneOntologyBiologicalProcess | peptide modification | 9.51e-05 | 10 | 195 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | A2M INHA INHBA SPATA31A7 ACRV1 UTP14A MAST2 SPATA31A6 GGT1 GGT3P PARP1 CFAP54 DLG1 ZSCAN2 HERC2 TARBP2 SPATA31A3 ADAM30 SPATA31A5 GGT2P ZFX IGF2R PAFAH1B3 SSH2 FAM9B TDRP | 1.07e-04 | 1235 | 195 | 26 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.72e-04 | 12 | 195 | 3 | GO:0098911 | |
| GeneOntologyCellularComponent | costamere | 4.80e-05 | 22 | 196 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | glucosidase complex | 8.75e-05 | 2 | 196 | 2 | GO:1902687 | |
| GeneOntologyCellularComponent | inhibin A complex | 8.75e-05 | 2 | 196 | 2 | GO:0043512 | |
| GeneOntologyCellularComponent | inhibin complex | 8.75e-05 | 2 | 196 | 2 | GO:0043511 | |
| GeneOntologyCellularComponent | glucosidase II complex | 8.75e-05 | 2 | 196 | 2 | GO:0017177 | |
| GeneOntologyCellularComponent | anchoring junction | CDH26 AHI1 STARD8 MAST2 DST SVIL NHS DLG1 DLG4 ABCC2 FLNB ANK3 DSG2 CAV1 AKAP12 SPTBN4 IGF2R ADGRE5 SSH2 PARD3 CDH3 PCDHGC3 | 1.30e-04 | 976 | 196 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | main axon | 1.92e-04 | 89 | 196 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | sarcolemma | 4.39e-04 | 190 | 196 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | intercalated disc | 4.45e-04 | 68 | 196 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | paranode region of axon | 5.01e-04 | 17 | 196 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | LGMN MAP1B INHBA DAB1 CMYA5 GGT1 GGT3P ITPR1 DST RASGRP3 DLG1 TARBP2 PCSK9 CAV1 GGT2P ALG2 IGF2R IGHMBP2 EML1 TRIM37 | 5.13e-04 | 934 | 196 | 20 | GO:0048471 |
| GeneOntologyCellularComponent | node of Ranvier | 8.23e-04 | 20 | 196 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | postsynaptic density | MAP1B CHRM3 ITPR1 DST DLG1 DLG4 SHANK1 ANK3 CLSTN1 PAK3 MACF1 IGSF9B | 1.18e-03 | 451 | 196 | 12 | GO:0014069 |
| MousePheno | hindlimb paralysis | 2.32e-06 | 79 | 153 | 8 | MP:0000755 | |
| MousePheno | limb paralysis | 3.38e-06 | 83 | 153 | 8 | MP:0013147 | |
| MousePheno | abnormal circulating glutathione level | 1.27e-05 | 5 | 153 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.27e-05 | 5 | 153 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 1.27e-05 | 5 | 153 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 1.27e-05 | 5 | 153 | 3 | MP:0012606 | |
| MousePheno | priapism | 1.27e-05 | 14 | 153 | 4 | MP:0003415 | |
| MousePheno | premature death | CFH SMG1 MAP1B INHA INHBA SPTB DAB1 GGT1 GGT3P ITPR1 CFAP54 DST SERPINI2 SRGAP3 UNG FLNB ANK3 SGCG ADAMTS13 CAV1 GGT2P AKAP12 SPTBN4 IGHMBP2 EML1 TRIM37 HYDIN | 2.56e-05 | 1051 | 153 | 27 | MP:0002083 |
| MousePheno | abnormal penile erection | 3.75e-05 | 18 | 153 | 4 | MP:0001379 | |
| MousePheno | skeletal muscle interstitial fibrosis | 4.36e-05 | 7 | 153 | 3 | MP:0003851 | |
| MousePheno | decreased circulating cysteine level | 4.36e-05 | 7 | 153 | 3 | MP:0030626 | |
| MousePheno | abnormal copulation physiology | 4.71e-05 | 19 | 153 | 4 | MP:0031627 | |
| MousePheno | paralysis | 4.82e-05 | 119 | 153 | 8 | MP:0000753 | |
| MousePheno | abnormal follicle stimulating hormone level | 5.33e-05 | 89 | 153 | 7 | MP:0003967 | |
| MousePheno | decreased cysteine level | 6.92e-05 | 8 | 153 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 6.92e-05 | 8 | 153 | 3 | MP:0004932 | |
| MousePheno | axonal dystrophy | 8.66e-05 | 22 | 153 | 4 | MP:0003225 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 9.75e-05 | 68 | 153 | 6 | MP:0003662 | |
| MousePheno | abnormal neurite morphology | MAP1B POGZ CMYA5 HNRNPAB DST SRGAP3 DLG4 MTCL1 HERC2 ZBTB18 CAV1 CLSTN1 SPTBN4 IGHMBP2 PAK3 | 1.02e-04 | 442 | 153 | 15 | MP:0008415 |
| MousePheno | abnormal subplate morphology | 1.03e-04 | 9 | 153 | 3 | MP:0008440 | |
| MousePheno | nervous | 1.03e-04 | 9 | 153 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 1.46e-04 | 10 | 153 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 1.46e-04 | 10 | 153 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 1.46e-04 | 10 | 153 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 1.99e-04 | 11 | 153 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 1.99e-04 | 11 | 153 | 3 | MP:0011130 | |
| MousePheno | increased circulating pituitary hormone level | 2.03e-04 | 110 | 153 | 7 | MP:0005117 | |
| MousePheno | abnormal circulating gonadotropin level | 2.27e-04 | 112 | 153 | 7 | MP:0003361 | |
| MousePheno | abnormal circulating estradiol level | 2.53e-04 | 52 | 153 | 5 | MP:0005183 | |
| MousePheno | abnormal dendrite morphology | 2.80e-04 | 237 | 153 | 10 | MP:0008143 | |
| MousePheno | abnormal visual acuity | 3.39e-04 | 13 | 153 | 3 | MP:0011832 | |
| MousePheno | abnormal cysteine level | 3.39e-04 | 13 | 153 | 3 | MP:0030621 | |
| MousePheno | decreased visual acuity | 3.39e-04 | 13 | 153 | 3 | MP:0006149 | |
| MousePheno | decreased glutathione level | 3.39e-04 | 13 | 153 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 3.39e-04 | 13 | 153 | 3 | MP:0012603 | |
| MousePheno | abnormal circulating estrogen level | 3.89e-04 | 57 | 153 | 5 | MP:0003369 | |
| MousePheno | absent suckling reflex | 4.28e-04 | 14 | 153 | 3 | MP:0001435 | |
| MousePheno | decreased effector memory CD8-positive, alpha-beta T cell number | 4.28e-04 | 14 | 153 | 3 | MP:0010851 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 4.96e-04 | 34 | 153 | 4 | MP:0002790 | |
| MousePheno | increased pituitary hormone level | 5.13e-04 | 128 | 153 | 7 | MP:0003973 | |
| MousePheno | impaired smooth muscle contractility | 5.55e-04 | 35 | 153 | 4 | MP:0000740 | |
| MousePheno | abnormal copulatory plug deposition | 6.48e-04 | 16 | 153 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 6.48e-04 | 16 | 153 | 3 | MP:0008477 | |
| MousePheno | abnormal muscle contractility | CMYA5 CHRM3 DST DLG1 COL6A3 SLC4A7 DSG2 ARHGEF12 NBEA CAV1 AKAP12 SPTBN4 TNNI3K | 6.85e-04 | 418 | 153 | 13 | MP:0005620 |
| MousePheno | abnormal Claudius cell morphology | 7.04e-04 | 4 | 153 | 2 | MP:0004430 | |
| MousePheno | mammary gland duct hyperplasia | 7.04e-04 | 4 | 153 | 2 | MP:0001885 | |
| MousePheno | decreased circulating estradiol level | 7.62e-04 | 38 | 153 | 4 | MP:0005181 | |
| MousePheno | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | 7.81e-04 | 17 | 153 | 3 | MP:0010169 | |
| MousePheno | abnormal reflex | MAP1B INHBA ZBTB43 DAB1 CMYA5 CHRM3 FBXO2 ITPR1 ZNF462 DST KCNJ13 MTMR3 NHS DLG4 SHANK1 SEMA3F ELP1 NBEA CAV1 ALG2 AKAP12 SPTBN4 IGF2R IGHMBP2 RBM6 PRKCSH EML1 | 7.84e-04 | 1294 | 153 | 27 | MP:0001961 |
| Domain | ACTININ_2 | 3.32e-06 | 23 | 194 | 5 | PS00020 | |
| Domain | ACTININ_1 | 3.32e-06 | 23 | 194 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.32e-06 | 23 | 194 | 5 | IPR001589 | |
| Domain | DUF4599 | 5.23e-06 | 12 | 194 | 4 | PF15371 | |
| Domain | DUF4599 | 5.23e-06 | 12 | 194 | 4 | IPR027970 | |
| Domain | CH | 5.77e-05 | 65 | 194 | 6 | SM00033 | |
| Domain | Spectrin | 8.56e-05 | 23 | 194 | 4 | PF00435 | |
| Domain | CH | 8.77e-05 | 70 | 194 | 6 | PF00307 | |
| Domain | - | 9.50e-05 | 71 | 194 | 6 | 1.10.418.10 | |
| Domain | PRT_C | 1.07e-04 | 2 | 194 | 2 | PF08372 | |
| Domain | PRibTrfase_C | 1.07e-04 | 2 | 194 | 2 | IPR013583 | |
| Domain | CH | 1.11e-04 | 73 | 194 | 6 | PS50021 | |
| Domain | CH-domain | 1.29e-04 | 75 | 194 | 6 | IPR001715 | |
| Domain | PDZ | 1.60e-04 | 148 | 194 | 8 | SM00228 | |
| Domain | - | 1.75e-04 | 150 | 194 | 8 | 2.30.42.10 | |
| Domain | PDZ | 1.84e-04 | 151 | 194 | 8 | PS50106 | |
| Domain | PDZ | 1.92e-04 | 152 | 194 | 8 | IPR001478 | |
| Domain | Spectrin_repeat | 2.19e-04 | 29 | 194 | 4 | IPR002017 | |
| Domain | SPEC | 3.23e-04 | 32 | 194 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.23e-04 | 32 | 194 | 4 | IPR018159 | |
| Domain | MAGUK_N_PEST | 6.35e-04 | 4 | 194 | 2 | PF10608 | |
| Domain | PDZ_assoc | 6.35e-04 | 4 | 194 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 6.35e-04 | 4 | 194 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 6.35e-04 | 4 | 194 | 2 | IPR019583 | |
| Domain | Spectrin_bsu | 6.35e-04 | 4 | 194 | 2 | IPR016343 | |
| Domain | MAGUK_N_PEST | 6.35e-04 | 4 | 194 | 2 | SM01277 | |
| Domain | DLG1 | 6.35e-04 | 4 | 194 | 2 | IPR016313 | |
| Domain | PDZ | 6.86e-04 | 141 | 194 | 7 | PF00595 | |
| Domain | NUT | 1.05e-03 | 5 | 194 | 2 | IPR024310 | |
| Domain | NUT_N | 1.05e-03 | 5 | 194 | 2 | IPR024309 | |
| Domain | Hexokinase_2 | 1.05e-03 | 5 | 194 | 2 | PF03727 | |
| Domain | NUT | 1.05e-03 | 5 | 194 | 2 | PF12881 | |
| Domain | Hexokinase_BS | 1.05e-03 | 5 | 194 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 1.05e-03 | 5 | 194 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 1.05e-03 | 5 | 194 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 1.05e-03 | 5 | 194 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 1.05e-03 | 5 | 194 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 1.05e-03 | 5 | 194 | 2 | PS00378 | |
| Domain | Semaphorin | 1.10e-03 | 20 | 194 | 3 | IPR027231 | |
| Domain | - | 1.57e-03 | 6 | 194 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.57e-03 | 6 | 194 | 2 | PS51460 | |
| Domain | - | 1.57e-03 | 6 | 194 | 2 | 2.70.130.10 | |
| Domain | GAS2 | 1.57e-03 | 6 | 194 | 2 | PF02187 | |
| Domain | Hexokinase | 1.57e-03 | 6 | 194 | 2 | IPR001312 | |
| Domain | - | 1.57e-03 | 6 | 194 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.57e-03 | 6 | 194 | 2 | IPR003108 | |
| Domain | GAS2 | 1.57e-03 | 6 | 194 | 2 | SM00243 | |
| Domain | GUANYLATE_KINASE_2 | 1.68e-03 | 23 | 194 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.68e-03 | 23 | 194 | 3 | PS00856 | |
| Domain | SH3 | 1.93e-03 | 216 | 194 | 8 | PS50002 | |
| Domain | EF-hand_5 | 2.14e-03 | 25 | 194 | 3 | PF13202 | |
| Domain | SH3_domain | 2.16e-03 | 220 | 194 | 8 | IPR001452 | |
| Domain | GGT_peptidase | 2.18e-03 | 7 | 194 | 2 | IPR000101 | |
| Domain | Plectin | 2.18e-03 | 7 | 194 | 2 | PF00681 | |
| Domain | G_glu_transpept | 2.18e-03 | 7 | 194 | 2 | PF01019 | |
| Domain | Plectin_repeat | 2.18e-03 | 7 | 194 | 2 | IPR001101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 2.18e-03 | 7 | 194 | 2 | PS00462 | |
| Domain | PLEC | 2.18e-03 | 7 | 194 | 2 | SM00250 | |
| Pubmed | NES EDC4 FBXO2 ZNF462 PARP1 DST SRGAP3 SVIL ZBTB21 DLG1 DLG4 MTCL1 HERC2 BEGAIN SHANK1 NOP56 ANK3 ARHGEF12 NBEA HUWE1 AKAP12 SPTBN4 IGF2R ZNF516 SMARCA4 PAK3 MACF1 EML1 SSH2 PARD3 PPP6R2 | 1.11e-14 | 963 | 202 | 31 | 28671696 | |
| Pubmed | LGMN HBS1L AHI1 USP45 STARD8 HK3 UTP14A ITPR1 AREL1 CRYBG1 DLG1 BAIAP3 QSOX2 DSE FLNB SLC4A7 NOP56 ANK3 HUWE1 AKAP12 IGF2R MACF1 SDF4 ADGRE5 PARD3 TRIM37 | 1.10e-09 | 1084 | 202 | 26 | 11544199 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES PPAN MAP1B UTP14A EDC4 HNRNPAB SCAF1 PARP1 GANAB DST SVIL ZBTB21 HERC2 FLNB NOP56 DSG2 ELP1 CCT2 HUWE1 IDH3A IGF2R PAFAH1B3 SMARCA4 MACF1 PRKCSH | 1.66e-09 | 1024 | 202 | 25 | 24711643 |
| Pubmed | ITPR1 PARP1 TOX4 GANAB SVIL MTMR3 NHS DLG1 UNG HERC2 FKBP5 ANK3 MTMR8 ELP1 XPO4 NBEA CCT2 HUWE1 IGF2R NOP14 KLHL15 SDF4 PRKCSH SSH2 PPP6R2 | 2.69e-09 | 1049 | 202 | 25 | 27880917 | |
| Pubmed | 8.28e-09 | 101 | 202 | 9 | 9872452 | ||
| Pubmed | A2M SMG1 HBS1L HK2 MAP1B UTP14A MAST2 ITPR1 DST DLG1 QSOX2 SEMA3C ARHGEF28 ELP1 CLSTN1 LRCH4 CLSPN PPP6R2 PCDHGC3 | 1.01e-08 | 650 | 202 | 19 | 38777146 | |
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.64e-08 | 6 | 202 | 4 | 25930072 | |
| Pubmed | NES MAP1B SPTB EDC4 HNRNPAB CRACD PARP1 DST SRGAP3 SVIL DLG1 DLG4 SHANK1 FLNB ANK3 ARHGEF12 ELP1 NBEA CCT2 IDH3A ALG2 SPTBN4 TENM4 SMARCA4 MACF1 SSH2 PPP6R2 | 7.77e-08 | 1431 | 202 | 27 | 37142655 | |
| Pubmed | PARP1 TNRC18 TOX4 DST SVIL MTCL1 FLNB HUWE1 CLSTN1 SMARCA4 MACF1 ALPK2 AHNAK2 | 8.68e-08 | 332 | 202 | 13 | 37433992 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 1.93e-07 | 3 | 202 | 3 | 2573352 | |
| Pubmed | HK2 MAP1B HMGCS1 EDC4 HNRNPAB ITPR1 TNRC18 SRGAP3 DLG1 DLG4 BEGAIN SHANK1 FLNB SLC4A7 ANK3 NBEA HUWE1 IDH3A TENM4 IGHMBP2 PAK3 MACF1 PPP6R2 | 2.40e-07 | 1139 | 202 | 23 | 36417873 | |
| Pubmed | SMG1 MYF6 HK2 SPTB CMYA5 MAST2 ZNF462 DST FLNB COL6A3 SGCG ELP1 AKAP12 MACF1 PARD3 | 2.55e-07 | 497 | 202 | 15 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 NES HBS1L MAP1B EDC4 CRACD PARP1 DST SRGAP3 SVIL FLNB NOP56 NBEA MACF1 JPT1 | 2.62e-07 | 498 | 202 | 15 | 36634849 |
| Pubmed | NES HK3 HNRNPAB RETREG3 ITPR1 CRACD PARP1 BEND7 SVIL FLNB DSG2 CAV1 AKAP12 IGF2R SSH2 | 2.97e-07 | 503 | 202 | 15 | 36217030 | |
| Pubmed | NES MAP1B UTP14A POGZ EDC4 GANAB DST HERC2 FLNB ELP1 CCT2 HUWE1 IGF2R NOP14 RBM6 SMARCA4 MACF1 | 3.20e-07 | 653 | 202 | 17 | 22586326 | |
| Pubmed | CFH SPTB ZBTB43 POGZ CMYA5 PARP1 DST MTMR3 DLG1 DLG4 HERC2 SHANK1 FLNB ANK3 NBEA CCT2 HUWE1 SPTBN4 FAIM SMARCA4 SENP6 MACF1 ST18 TRIM37 | 5.24e-07 | 1285 | 202 | 24 | 35914814 | |
| Pubmed | 5.54e-07 | 28 | 202 | 5 | 35666215 | ||
| Pubmed | 1.06e-06 | 14 | 202 | 4 | 18357469 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DST SVIL CRYBG1 NHS DLG1 FLNB SLC4A7 NOP56 ANK3 DSG2 ARHGEF12 IGF2R MACF1 JPT1 PARD3 | 1.27e-06 | 565 | 202 | 15 | 25468996 |
| Pubmed | GANAB DST NHS DLG1 SLC4A7 ANK3 SASH1 DSG2 AKAP12 IGF2R MACF1 PRKCSH PARD3 | 1.28e-06 | 421 | 202 | 13 | 36976175 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 23615310 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 11003618 | ||
| Pubmed | Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. | 1.91e-06 | 5 | 202 | 3 | 2904146 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 10392451 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 11089562 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 1.91e-06 | 5 | 202 | 3 | 12225953 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 7775425 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 9139708 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 9546365 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 1.91e-06 | 5 | 202 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 1.91e-06 | 5 | 202 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 1.91e-06 | 5 | 202 | 3 | 24698228 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 1.91e-06 | 5 | 202 | 3 | 18063838 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 11095909 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 7641802 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 9627710 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 12453183 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 2891746 | ||
| Pubmed | Expression of multiple gamma-glutamyltransferase genes in man. | 1.91e-06 | 5 | 202 | 3 | 7906515 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 1.91e-06 | 5 | 202 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 1.91e-06 | 5 | 202 | 3 | 8566783 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 30591459 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 1.91e-06 | 5 | 202 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 1.91e-06 | 5 | 202 | 3 | 19760322 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 2767687 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDH26 MAP1B SPTB DAB1 EIPR1 CHRM3 ZNF462 TNRC18 ANKAR TOX3 SEMA3B DLG1 BAIAP3 FKBP5 PRUNE2 FLNB ANK3 HUWE1 SPTBN4 RBM6 PAK3 MACF1 IGSF9B PARD3 MCTP2 | 2.05e-06 | 1489 | 202 | 25 | 28611215 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH LGMN MAP1B PIEZO1 ITPR1 GANAB SVIL SEMA3B QSOX2 DSE PCSK9 SEMA3F SEMA3C COL15A1 DSG2 CAV1 CLSTN1 IGF2R SDF4 ADGRE5 PRKCSH PPP6R2 | 2.21e-06 | 1201 | 202 | 22 | 35696571 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B UTP14A EDC4 HNRNPAB CRACD PARP1 TOX4 DST ZBTB21 NOP56 DSG2 CCT2 AKAP12 SMARCA4 SENP6 MACF1 JPT1 PPP6R2 AHNAK2 | 2.55e-06 | 934 | 202 | 19 | 33916271 |
| Pubmed | 3.17e-06 | 18 | 202 | 4 | 33323119 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES MAP1B EDC4 MAST2 DST SVIL ZBTB21 NHS MTCL1 SLC4A7 ARHGEF28 CAMKK1 SASH1 DSG2 MACF1 SSH2 PARD3 AHNAK2 | 3.26e-06 | 861 | 202 | 18 | 36931259 |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 3.81e-06 | 6 | 202 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 3.81e-06 | 6 | 202 | 3 | 8104871 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 11463821 | ||
| Pubmed | Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. | 3.81e-06 | 6 | 202 | 3 | 11231073 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 25326709 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 12163373 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 22242126 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 17363454 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 8663190 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 17942483 | ||
| Pubmed | HBS1L MAP1B PARP1 GANAB DST DLG1 FLNB NOP56 ANK3 DSG2 ARHGEF12 CCT2 AKAP12 IGF2R MACF1 PARD3 | 4.43e-06 | 708 | 202 | 16 | 39231216 | |
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 4.98e-06 | 20 | 202 | 4 | 21658587 | |
| Pubmed | ZBTB43 POGZ CRACD GANAB SRGAP3 MTMR3 MTCL1 BAIAP3 ARHGEF12 TENM4 MACF1 ST18 | 5.27e-06 | 407 | 202 | 12 | 12693553 | |
| Pubmed | PIEZO1 UTP14A ITPR1 PARP1 GANAB GMDS DLG1 HERC2 TARBP2 FKBP5 SLC4A7 NOP56 ANK3 DSG2 ELP1 CAV1 AKAP12 IGF2R NOP14 MACF1 SDF4 PRKCSH PARD3 PPP6R2 | 6.47e-06 | 1487 | 202 | 24 | 33957083 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 6.64e-06 | 7 | 202 | 3 | 32284594 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 36685533 | ||
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 6.64e-06 | 7 | 202 | 3 | 1968405 | |
| Pubmed | HBS1L STARD8 UTP14A ZNF462 TNRC18 TOX4 RASGRP3 PRUNE2 ARHGEF28 CLSTN1 MACF1 SSH2 PPP6R2 | 7.10e-06 | 493 | 202 | 13 | 15368895 | |
| Pubmed | POGZ MAST2 ARL6IP4 SCAF1 HMCN2 ZBTB21 DLG4 TARBP2 QSOX2 DSG2 ECT2L CAV1 ARHGEF33 MCTP1 SMARCA4 MACF1 SDF4 LTK CLSPN PARD3 | 9.04e-06 | 1116 | 202 | 20 | 31753913 | |
| Pubmed | NES SPTB GANAB DST SVIL FLNB DSG2 AKAP12 MACF1 PRKCSH AHNAK2 | 9.38e-06 | 360 | 202 | 11 | 33111431 | |
| Pubmed | Semaphorins III and IV repel hippocampal axons via two distinct receptors. | 1.06e-05 | 8 | 202 | 3 | 9753685 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 11906695 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 20006658 | ||
| Pubmed | 1.07e-05 | 24 | 202 | 4 | 32212159 | ||
| Pubmed | 1.58e-05 | 54 | 202 | 5 | 36237976 | ||
| Pubmed | 1.77e-05 | 251 | 202 | 9 | 27507650 | ||
| Pubmed | 2.03e-05 | 28 | 202 | 4 | 18617019 | ||
| Pubmed | HBS1L MAP1B POGZ EDC4 TOX4 DLG1 NOP56 ANK3 DSG2 CCT2 HUWE1 SMARCA4 PARD3 | 2.20e-05 | 549 | 202 | 13 | 38280479 | |
| Pubmed | HBS1L PPAN PIEZO1 UTP14A EDC4 SCAF1 CRACD DST CRYBG1 DLG1 HERC2 TARBP2 SEMA3C SLC4A7 DSG2 ARHGEF12 ECT2L NOP14 IGHMBP2 LRCH4 RBM6 MACF1 PARD3 | 2.23e-05 | 1497 | 202 | 23 | 31527615 | |
| Pubmed | Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. | 2.25e-05 | 10 | 202 | 3 | 25173105 | |
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 23863468 | ||
| Pubmed | HK2 PARP1 TOX4 DST SVIL FKBP5 NOP56 ANK3 DSG2 IGF2R LRCH4 SMARCA4 MACF1 SDF4 | 2.29e-05 | 634 | 202 | 14 | 34591612 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | LGMN PPAN USP45 MAP1B ATG2A PARP1 DLG1 MTCL1 RPL22L1 HERC2 FKBP5 FLNB HUWE1 IDH3A IGF2R KLHL15 SDF4 PPP6R2 | 2.60e-05 | 1005 | 202 | 18 | 19615732 |
| Pubmed | NES STARD8 TOX4 GANAB SRGAP3 DLG1 RPL22L1 ARHGEF28 NOP56 ARHGEF12 ECT2L NBEA HUWE1 LRCH4 RBM6 SMARCA4 PRKCSH | 2.82e-05 | 916 | 202 | 17 | 32203420 | |
| Pubmed | PRTG PIEZO1 SPTB RIPOR3 MAST2 ARSI HERC2P3 ITPR1 TNRC18 MAP3K15 HERC2 ZBTB18 COL6A3 SEMA3C NOP56 DSG2 RNF146 CDH3 TRIM37 TDRP | 3.04e-05 | 1215 | 202 | 20 | 15146197 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 3.08e-05 | 11 | 202 | 3 | 26319580 | |
| Pubmed | Evidence for intrinsic development of olfactory structures in Pax-6 mutant mice. | 3.08e-05 | 11 | 202 | 3 | 11074448 | |
| Interaction | H2BC5 interactions | A2M PPAN MAP1B SCAF1 PARP1 TNRC18 DST SVIL HUWE1 IGF2R NOP14 PHF20L1 ATG3 PCDHGC3 | 4.47e-06 | 331 | 195 | 14 | int:H2BC5 |
| Interaction | TNIK interactions | NES EDC4 ZNF462 DST SRGAP3 DLG1 DLG4 HERC2 SHANK1 NOP56 ANK3 NBEA CAV1 HUWE1 MACF1 | 4.83e-06 | 381 | 195 | 15 | int:TNIK |
| Interaction | ARHGEF18 interactions | 7.52e-06 | 49 | 195 | 6 | int:ARHGEF18 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.79e-06 | 13 | 131 | 4 | 564 | |
| GeneFamily | PDZ domain containing | 1.50e-05 | 152 | 131 | 8 | 1220 | |
| GeneFamily | Multiple C2 and transmembrane domain containing | 5.21e-05 | 2 | 131 | 2 | 826 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.87e-04 | 20 | 131 | 3 | 736 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.34e-04 | 134 | 131 | 6 | 861 | |
| GeneFamily | CD molecules|MRH domain containing | 7.67e-04 | 6 | 131 | 2 | 1233 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 8.56e-04 | 26 | 131 | 3 | 904 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.07e-03 | 7 | 131 | 2 | 1113 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.18e-03 | 29 | 131 | 3 | 396 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.42e-03 | 8 | 131 | 2 | 939 | |
| GeneFamily | Collagens | 4.50e-03 | 46 | 131 | 3 | 490 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 5.14e-03 | 15 | 131 | 2 | 903 | |
| GeneFamily | EF-hand domain containing | 5.26e-03 | 219 | 131 | 6 | 863 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.37e-03 | 161 | 131 | 5 | 593 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | SVIL NHS DLG1 FKBP5 PRUNE2 ANK3 SASH1 NBEA AKAP12 SSH2 PARD3 ALPK2 | 1.12e-08 | 176 | 199 | 12 | M39223 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | PPAN UTP14A PARP1 DST SVIL SEMA3B UNG RPL22L1 FKBP5 FLNB CAV1 HUWE1 DPH5 ZNF516 CDH3 AHNAK2 | 3.57e-06 | 534 | 199 | 16 | M12522 |
| Coexpression | KASLER_HDAC7_TARGETS_1_DN | 7.10e-06 | 17 | 199 | 4 | MM911 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_DN | 7.10e-06 | 17 | 199 | 4 | M2318 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 2.36e-05 | 200 | 199 | 9 | M9391 | |
| Coexpression | GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN | 2.36e-05 | 200 | 199 | 9 | M3222 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 2.36e-05 | 200 | 199 | 9 | M5566 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP | 2.66e-05 | 203 | 199 | 9 | M10184 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 5.04e-05 | 86 | 199 | 6 | M39248 | |
| Coexpression | ELVIDGE_HYPOXIA_UP | 5.12e-05 | 171 | 199 | 8 | M7363 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | CFH ZBTB43 SLC12A8 ATG2A TOX3 ZBTB18 BAIAP3 DSE PGBD5 FLNB AKAP12 JPT1 AHNAK2 | 5.57e-05 | 461 | 199 | 13 | M14127 |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN | 6.28e-05 | 176 | 199 | 8 | M6757 | |
| Coexpression | LEE_BMP2_TARGETS_DN | PPAN USP45 HK2 PXDC1 HNRNPAB PARP1 UNG QSOX2 FKBP5 PARM1 FOXN2 NOP56 XPO4 IDH3A FAIM RASGRP1 PHF20L1 CLSPN MCTP2 | 6.43e-05 | 904 | 199 | 19 | M2325 |
| Coexpression | ELVIDGE_HYPOXIA_BY_DMOG_UP | 6.92e-05 | 132 | 199 | 7 | M9197 | |
| Coexpression | GABRIELY_MIR21_TARGETS | PARP1 RASGRP3 CRYBG1 DLG1 SASH1 ARHGEF12 NBEA RASGRP1 PHF20L1 KLHL15 | 7.78e-05 | 289 | 199 | 10 | M2196 |
| Coexpression | LEE_BMP2_TARGETS_DN | PPAN USP45 HK2 PXDC1 HNRNPAB PARP1 UNG QSOX2 FKBP5 PARM1 FOXN2 NOP56 XPO4 IDH3A FAIM RASGRP1 PHF20L1 CLSPN MCTP2 | 8.34e-05 | 922 | 199 | 19 | MM1068 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.75e-05 | 137 | 199 | 7 | M39241 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 8.81e-05 | 95 | 199 | 6 | M1111 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | POGZ HNRNPAB ITPR1 PARP1 SVIL TOX3 HERC2 PGBD5 PARM1 PRUNE2 FOXN2 SASH1 ELP1 IDH3A ACBD6 DPH5 PAFAH1B3 SMARCA4 SSH2 PARD3 | 9.15e-05 | 1009 | 199 | 20 | M157 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 9.22e-05 | 295 | 199 | 10 | M39063 | |
| Coexpression | ATF2_S_UP.V1_DN | 9.59e-05 | 187 | 199 | 8 | M2681 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.09e-04 | 62 | 199 | 5 | M16774 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.38e-04 | 103 | 199 | 6 | MM476 | |
| Coexpression | RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP | 1.42e-04 | 148 | 199 | 7 | M39016 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 1.42e-04 | 198 | 199 | 8 | M9396 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | HMGCS1 EDC4 GGT1 GGT3P RETREG3 FKBP5 COL11A1 ANK3 CCT2 HUWE1 GGT2P TENM4 RBM6 SMARCA4 CDH3 | 1.43e-04 | 650 | 199 | 15 | MM1042 |
| Coexpression | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN | 1.45e-04 | 104 | 199 | 6 | M6189 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 1.47e-04 | 199 | 199 | 8 | M7998 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.47e-04 | 199 | 199 | 8 | M5406 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN | 1.53e-04 | 200 | 199 | 8 | M3571 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP | 1.53e-04 | 200 | 199 | 8 | M8860 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP | 1.53e-04 | 200 | 199 | 8 | M6067 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | NES AHI1 MAP1B CRACD SRGAP3 SNRNP35 ARHGEF12 ZFX PAK3 ST18 TRIM37 | 9.06e-06 | 225 | 198 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH NES HK2 INHA INHBA PIEZO1 SRGAP3 RASGRP3 SVIL QSOX2 FKBP5 DSE PGBD5 COL6A3 SEMA3C NOP56 TENM4 PAK3 CLSPN CDH3 | 3.55e-05 | 768 | 198 | 20 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.44e-05 | 137 | 198 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M DAB1 CHRM3 ITPR1 HMCN2 SVIL NHS PARM1 PRUNE2 FLNB ARHGEF28 MACF1 ADGRE5 | 3.95e-12 | 188 | 202 | 13 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | AHI1 MAP1B FBXL22 DST SVIL MTCL1 PRUNE2 COL6A3 SEMA3C ANK3 PAK3 CDH3 | 1.41e-10 | 200 | 202 | 12 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | A2M DAB1 CHRM3 ITPR1 HMCN2 NHS PRUNE2 FLNB ARHGEF28 MACF1 ADGRE5 | 1.16e-09 | 189 | 202 | 11 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH MAP1B RIPOR3 DST PARM1 COL6A3 SEMA3C COL15A1 AKAP12 ADGRE5 | 1.53e-09 | 194 | 202 | 11 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH MAP1B RIPOR3 DST PARM1 COL6A3 SEMA3C COL15A1 AKAP12 ADGRE5 | 1.53e-09 | 194 | 202 | 11 | df82cce5ebeb73740b02cf816c6df82253cfd566 |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | CFH SLC12A8 CMYA5 CHRM3 SRGAP3 TOX3 NHS GMDS ARHGEF28 NBEA ITPRID1 | 2.11e-09 | 200 | 202 | 11 | 682960e28542a3d6c119047cd0131941932cfdea |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-08 | 186 | 202 | 10 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.51e-08 | 187 | 202 | 10 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-08 | 191 | 202 | 10 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-08 | 191 | 202 | 10 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | CFAP54 ANK3 ARHGEF12 CAV1 DNAH12 MACF1 CLSPN PARD3 MCTP2 HYDIN | 2.36e-08 | 196 | 202 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | CFAP54 ANK3 ARHGEF12 CAV1 DNAH12 MACF1 CLSPN PARD3 MCTP2 HYDIN | 2.36e-08 | 196 | 202 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH MAP1B RIPOR3 PARM1 COL6A3 SEMA3C COL15A1 AKAP12 ADGRE5 | 2.47e-08 | 197 | 202 | 10 | 80e153790cef37b743e22a7370ff5b3a6abf147d |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SLC12A8 CHRM3 SRGAP3 TOX3 GMDS FLNB ARHGEF28 ANK3 NBEA MCTP2 | 2.85e-08 | 200 | 202 | 10 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.33e-08 | 169 | 202 | 9 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.33e-08 | 169 | 202 | 9 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-07 | 178 | 202 | 9 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.36e-07 | 179 | 202 | 9 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-07 | 182 | 202 | 9 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-07 | 182 | 202 | 9 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.64e-07 | 183 | 202 | 9 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-07 | 183 | 202 | 9 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.64e-07 | 183 | 202 | 9 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-07 | 185 | 202 | 9 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.97e-07 | 187 | 202 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-07 | 188 | 202 | 9 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 188 | 202 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.06e-07 | 188 | 202 | 9 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-07 | 189 | 202 | 9 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.16e-07 | 189 | 202 | 9 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-07 | 189 | 202 | 9 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-07 | 191 | 202 | 9 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.47e-07 | 192 | 202 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 193 | 202 | 9 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.58e-07 | 193 | 202 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 193 | 202 | 9 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-07 | 194 | 202 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 195 | 202 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 195 | 202 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.07e-07 | 197 | 202 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.07e-07 | 197 | 202 | 9 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.07e-07 | 197 | 202 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.34e-07 | 199 | 202 | 9 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 202 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 202 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 157 | 202 | 8 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 8.23e-07 | 163 | 202 | 8 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 168 | 202 | 8 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-06 | 168 | 202 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 168 | 202 | 8 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 172 | 202 | 8 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 176 | 202 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.47e-06 | 176 | 202 | 8 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-06 | 178 | 202 | 8 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 178 | 202 | 8 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-06 | 179 | 202 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 181 | 202 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 182 | 202 | 8 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.88e-06 | 182 | 202 | 8 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 182 | 202 | 8 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 182 | 202 | 8 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.13e-06 | 185 | 202 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.13e-06 | 185 | 202 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.13e-06 | 185 | 202 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 186 | 202 | 8 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 186 | 202 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 186 | 202 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-06 | 187 | 202 | 8 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-06 | 187 | 202 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.30e-06 | 187 | 202 | 8 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-06 | 187 | 202 | 8 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 187 | 202 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 188 | 202 | 8 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 188 | 202 | 8 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 188 | 202 | 8 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 188 | 202 | 8 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 188 | 202 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.49e-06 | 189 | 202 | 8 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 189 | 202 | 8 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 189 | 202 | 8 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 190 | 202 | 8 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 190 | 202 | 8 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 190 | 202 | 8 | a318d80dd5cc33d43048883b0e7844b5aa280aab | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.59e-06 | 190 | 202 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-06 | 190 | 202 | 8 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 190 | 202 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 190 | 202 | 8 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.59e-06 | 190 | 202 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 191 | 202 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 191 | 202 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 192 | 202 | 8 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 192 | 202 | 8 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 192 | 202 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 192 | 202 | 8 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 192 | 202 | 8 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 6.51e-08 | 7 | 196 | 4 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.29e-07 | 8 | 196 | 4 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | glucosidase 2 subunit beta measurement | 5.69e-06 | 6 | 196 | 3 | EFO_0801628 | |
| Disease | glaucoma | 9.37e-06 | 154 | 196 | 8 | MONDO_0005041 | |
| Disease | calcium/calmodulin-dependent protein kinase kinase 1 measurement | 4.39e-05 | 2 | 196 | 2 | EFO_0020217 | |
| Disease | hemoglobin A1 measurement | HBS1L PIEZO1 SPTB SLC12A8 MAST2 HNRNPAB SRGAP3 MTMR3 MAP3K15 ADAM30 RASGRP1 MACF1 PRKCSH | 4.91e-05 | 520 | 196 | 13 | EFO_0007629 |
| Disease | brain measurement, neuroimaging measurement | PRTG DAB1 SLC12A8 ZNF462 TOX3 COL11A1 ANK3 MCTP1 LRCH4 MACF1 EML1 SSH2 PARD3 | 8.64e-05 | 550 | 196 | 13 | EFO_0004346, EFO_0004464 |
| Disease | neuroimaging measurement | PRTG MAP1B DAB1 SLC12A8 RETREG3 ZNF462 RASGRP3 TOX3 SLC4A9 QSOX2 COL11A1 ANK3 ARHGEF12 LRCH4 MACF1 PRKCSH EML1 SSH2 PARD3 | 1.01e-04 | 1069 | 196 | 19 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | STARD8 HK3 PXDC1 PARP1 FCRL3 SRGAP3 BEND7 TOX3 MTMR3 NHS HERC2 FLNB COL11A1 MTMR8 ELP1 CAV1 AKAP12 MACF1 CLSPN | 1.07e-04 | 1074 | 196 | 19 | C0006142 |
| Disease | atypical hemolytic-uremic syndrome (is_marker_for) | 1.31e-04 | 3 | 196 | 2 | DOID:0080301 (is_marker_for) | |
| Disease | pulse pressure measurement | CFH MAP1B INHBA POGZ MAST2 AREL1 GMDS QSOX2 FLNB COL6A3 COL11A1 SLC4A7 COL15A1 ARHGEF12 NBEA CAV1 SPTBN4 TENM4 ZNF516 EML1 ST18 HYDIN | 1.54e-04 | 1392 | 196 | 22 | EFO_0005763 |
| Disease | cortical thickness | A2M PRTG INHBA DAB1 SLC12A8 MAST2 ZNF462 SRGAP3 TOX3 MTMR3 MTCL1 FLNB COL11A1 ARHGEF12 MACF1 EML1 SSH2 PARD3 ST18 | 1.69e-04 | 1113 | 196 | 19 | EFO_0004840 |
| Disease | multiple sclerosis | HBS1L AHI1 ITPR1 METTL1 FCRL3 SVIL RASGRP1 IGF2R MCTP1 SMARCA4 CARD11 CDH3 ALPK2 | 1.84e-04 | 594 | 196 | 13 | MONDO_0005301 |
| Disease | Intellectual Disability | AHI1 MAP1B POGZ ZNF462 PARP1 SRGAP3 DLG4 NBEA ACBD6 KLHL15 MACF1 | 2.15e-04 | 447 | 196 | 11 | C3714756 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.61e-04 | 4 | 196 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | adhesion G protein-coupled receptor E2 measurement | 2.61e-04 | 4 | 196 | 2 | EFO_0021892 | |
| Disease | palmitoyl sphingomyelin (d18:1/16:0) measurement | 2.61e-04 | 4 | 196 | 2 | EFO_0800300 | |
| Disease | open-angle glaucoma | 3.02e-04 | 191 | 196 | 7 | EFO_0004190 | |
| Disease | descending aortic diameter | 3.08e-04 | 88 | 196 | 5 | EFO_0021788 | |
| Disease | Endometrial Stromal Sarcoma | 4.33e-04 | 5 | 196 | 2 | C0206630 | |
| Disease | beta-1,4-galactosyltransferase 6 measurement | 4.33e-04 | 5 | 196 | 2 | EFO_0801411 | |
| Disease | polycystic liver disease (is_implicated_in) | 4.33e-04 | 5 | 196 | 2 | DOID:0050770 (is_implicated_in) | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 4.33e-04 | 5 | 196 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | vital capacity | CFH AHI1 INHBA FSIP1 PIEZO1 ZBTB43 ITPR1 DST MTMR3 GMDS DLG1 MTCL1 QSOX2 FKBP5 COL6A3 FOXN2 NOP14 PARD3 PPP6R2 | 6.18e-04 | 1236 | 196 | 19 | EFO_0004312 |
| Disease | Clear cell sarcoma of kidney | 6.47e-04 | 6 | 196 | 2 | C0334488 | |
| Disease | riboflavin kinase measurement | 6.47e-04 | 6 | 196 | 2 | EFO_0802016 | |
| Disease | hair colour measurement | HBS1L INHBA PIEZO1 ATG2A TOX3 GMDS HERC2 SASH1 AKAP12 TENM4 IGHMBP2 PARD3 | 8.93e-04 | 615 | 196 | 12 | EFO_0007822 |
| Disease | atrial natriuretic factor measurement | 9.02e-04 | 7 | 196 | 2 | EFO_0004789 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 9.02e-04 | 7 | 196 | 2 | EFO_0800400 | |
| Disease | free cholesterol measurement | 9.66e-04 | 113 | 196 | 5 | EFO_0008591 | |
| Disease | coronary artery disease | HBS1L MAP1B DAB1 VWDE CRACD PARP1 KCNJ13 GMDS FKBP5 PCSK9 COL6A3 SEMA3C ARHGEF12 AKAP12 IGF2R SMARCA4 EML1 MCTP2 | 1.07e-03 | 1194 | 196 | 18 | EFO_0001645 |
| Disease | Nonorganic psychosis | 1.17e-03 | 69 | 196 | 4 | C0349204 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.17e-03 | 118 | 196 | 5 | EFO_0010119 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.20e-03 | 8 | 196 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 1.20e-03 | 8 | 196 | 2 | C0887850 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin concentration | 1.20e-03 | 8 | 196 | 2 | EFO_0004509, EFO_0004528 | |
| Disease | FEV/FEC ratio | UTP14A CHRM3 ITPR1 FBXL22 DST SRGAP3 RASGRP3 SVIL MTMR3 GMDS MTCL1 COL6A3 COL15A1 ARHGEF28 DNAH12 ZNF516 SSH2 PARD3 | 1.46e-03 | 1228 | 196 | 18 | EFO_0004713 |
| Disease | psychotic symptoms | 1.51e-03 | 74 | 196 | 4 | EFO_0005940 | |
| Disease | angina pectoris | 1.51e-03 | 125 | 196 | 5 | EFO_0003913 | |
| Disease | beta-mannosidase measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0801421 | |
| Disease | low tension glaucoma | 1.53e-03 | 9 | 196 | 2 | EFO_1001022 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.53e-03 | 9 | 196 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Endomyocardial Fibrosis | 1.53e-03 | 9 | 196 | 2 | C0553980 | |
| Disease | refractive error | 1.59e-03 | 326 | 196 | 8 | MONDO_0004892 | |
| Disease | cortical surface area measurement | PRTG FSIP1 DAB1 SLC12A8 MAST2 TOX3 MTCL1 ZBTB18 FLNB SEMA3C COL11A1 ANK3 ARHGEF12 CLSTN1 MACF1 EML1 SSH2 PARD3 MCTP2 | 1.65e-03 | 1345 | 196 | 19 | EFO_0010736 |
| Disease | Nephroblastoma | 1.91e-03 | 10 | 196 | 2 | Orphanet_654 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 1.91e-03 | 10 | 196 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.91e-03 | 10 | 196 | 2 | GO_0097327, GO_0097328 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.94e-03 | 194 | 196 | 6 | EFO_0004265, EFO_0007908 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.32e-03 | 11 | 196 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | primary angle closure glaucoma | 2.32e-03 | 11 | 196 | 2 | EFO_1001506 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | serum non-albumin protein measurement | 2.98e-03 | 361 | 196 | 8 | EFO_0004568 | |
| Disease | lipid measurement, lipoprotein measurement | 3.09e-03 | 90 | 196 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | nevus count, cutaneous melanoma | 3.22e-03 | 91 | 196 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | MAP kinase-activated protein kinase 3 measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0008226 | |
| Disease | Neurodevelopmental Disorders | 3.48e-03 | 93 | 196 | 4 | C1535926 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 3.61e-03 | 94 | 196 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.79e-03 | 14 | 196 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, APOE carrier status | 4.19e-03 | 98 | 196 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | HIV-1 infection | 4.19e-03 | 98 | 196 | 4 | EFO_0000180 | |
| Disease | phospholipids in medium LDL measurement | 4.25e-03 | 49 | 196 | 3 | EFO_0022183 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.25e-03 | 49 | 196 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | cholesterol in medium LDL measurement | 4.25e-03 | 49 | 196 | 3 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 4.25e-03 | 49 | 196 | 3 | EFO_0022227 | |
| Disease | Alopecia, Male Pattern | 4.35e-03 | 15 | 196 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 4.35e-03 | 15 | 196 | 2 | C0162311 | |
| Disease | anemia (implicated_via_orthology) | 4.35e-03 | 15 | 196 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Female pattern alopecia (disorder) | 4.35e-03 | 15 | 196 | 2 | C0263477 | |
| Disease | Psychotic Disorders | 4.67e-03 | 101 | 196 | 4 | C0033975 | |
| Disease | white matter microstructure measurement | 4.73e-03 | 390 | 196 | 8 | EFO_0005674 | |
| Disease | platelet component distribution width | HBS1L AHI1 STARD8 RIPOR3 TOX4 SVIL PRUNE2 SLC4A7 CAV1 RBM6 MACF1 ADGRE5 | 4.80e-03 | 755 | 196 | 12 | EFO_0007984 |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 4.95e-03 | 16 | 196 | 2 | OBA_2045195 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 5.00e-03 | 103 | 196 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | phospholipids in medium VLDL measurement | 5.02e-03 | 52 | 196 | 3 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 5.02e-03 | 52 | 196 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 5.02e-03 | 52 | 196 | 3 | EFO_0022308 | |
| Disease | corpus callosum posterior volume measurement | 5.02e-03 | 52 | 196 | 3 | EFO_0010298 | |
| Disease | cholesterol in small VLDL measurement | 5.30e-03 | 53 | 196 | 3 | EFO_0022228 | |
| Disease | Abnormality of refraction | SMG1 ZNF462 MTMR3 QSOX2 ANK3 NBEA CAV1 ZNF516 FAM9B PARD3 ST18 | 5.57e-03 | 673 | 196 | 11 | HP_0000539 |
| Disease | gestational diabetes (is_marker_for) | 5.59e-03 | 17 | 196 | 2 | DOID:11714 (is_marker_for) | |
| Disease | hyperglycemia (implicated_via_orthology) | 5.59e-03 | 17 | 196 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | esophageal carcinoma, gastric carcinoma | 5.59e-03 | 17 | 196 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | clonal hematopoiesis mutation measurement | 5.88e-03 | 55 | 196 | 3 | EFO_0020949 | |
| Disease | remnant cholesterol measurement | 5.91e-03 | 108 | 196 | 4 | EFO_0010815 | |
| Disease | vascular endothelial growth factor measurement | 6.18e-03 | 56 | 196 | 3 | EFO_0004762 | |
| Disease | sphingosine 1-phosphate measurement | 6.26e-03 | 18 | 196 | 2 | EFO_0800185 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 6.26e-03 | 18 | 196 | 2 | OBA_2045175 | |
| Disease | peak expiratory flow | 6.32e-03 | 498 | 196 | 9 | EFO_0009718 | |
| Disease | total lipids in large LDL | 6.49e-03 | 57 | 196 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 6.49e-03 | 57 | 196 | 3 | EFO_0021901 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 6.51e-03 | 111 | 196 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | chronic obstructive pulmonary disease | PIEZO1 CHRM3 SRGAP3 RASGRP3 SVIL MTMR3 MTCL1 COL6A3 ARHGEF28 TENM4 SSH2 | 6.54e-03 | 688 | 196 | 11 | EFO_0000341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSTDIEDFVHPGHGD | 186 | P13051 | |
| HVVIAGESKDSPFEG | 36 | Q5JXB2 | |
| KGLEPEHSFSGSDSE | 951 | Q96Q91 | |
| NGGSSLTFEHPLDDV | 1721 | Q96N23 | |
| ESKTHFRAVDPDGDG | 141 | Q9BRK5 | |
| ANGTAGPTEDHTDDF | 331 | O94812 | |
| FSEGDDLSQGHLAEP | 476 | Q9BUH8 | |
| HHESSSVDTEPGLEE | 566 | Q8N157 | |
| SIPEDKHAGGTEERF | 1026 | Q86TB3 | |
| EDSIAGSGVEHSTPD | 781 | Q02952 | |
| DVGYHGSDIETPTLD | 61 | Q5FYB1 | |
| GTDNPHIGDDSSIFI | 241 | Q12959 | |
| FTFPNGEAVEHGEES | 631 | O95267 | |
| SGTEAETENFVHPTG | 271 | P20309 | |
| FSHLESSDGEAGRDP | 466 | P48960 | |
| TAGPEAVRDTGIHSE | 481 | A8MVX0 | |
| EEGSEDEGESTHLLP | 151 | Q8NEA5 | |
| VATEEEGGHVDFFVP | 381 | Q008S8 | |
| VEESTCGDIPELEHG | 686 | P08603 | |
| ETEPVTVASAGGDLH | 516 | O94985 | |
| SGDDSGEVEFPHSPE | 21 | Q9BR61 | |
| IDFEDVIAEPEGTHS | 66 | Q03135 | |
| GEPAATEHAEGEHTV | 96 | P26436 | |
| TEHAEGEHTVGEQPS | 101 | P26436 | |
| FLDTVVRVEHSPGDG | 171 | Q2TAZ0 | |
| TGVITPEEFVAAGDH | 31 | Q9NT62 | |
| TEDTGFDLGVTIAHE | 211 | Q76LX8 | |
| SGGRTEHPFTVEEFV | 211 | P01023 | |
| IAPHIIGAEDDDFGT | 346 | Q9NZN5 | |
| HCGSPTEADLSGEID | 146 | Q2M243 | |
| TPNDDTLDEGVGLVH | 471 | Q01581 | |
| HPQGSLDTGEEAEEV | 181 | P08476 | |
| VEASTHPDALVGTGF | 441 | Q6ZRP7 | |
| HEDFTFGESRPELGS | 541 | Q6P2E9 | |
| GEEFTEGEHPETLSR | 1061 | Q9Y4B5 | |
| EVGRAGHEDSTEPFP | 1456 | Q9Y4B5 | |
| GHSIRHPDVEVDGFS | 61 | P09874 | |
| FEVPGVSSEENGHSF | 176 | Q9Y450 | |
| FLDADPGFVHSDGTI | 171 | Q15102 | |
| GSDEGEVHTPFQASV | 936 | Q9UPP5 | |
| FIDSHVPGEDEERGT | 356 | O75427 | |
| ALDADSEGEGHSEPS | 481 | Q8N1W1 | |
| HGGIEFDISTPSIEN | 381 | Q7Z5J8 | |
| VVGDPFGATTHSDLV | 81 | Q9H2P9 | |
| PDFGLEESGHSNSTI | 1086 | Q14126 | |
| VAFTVGEGEDHDIPI | 186 | Q13451 | |
| PDDGGTAHLSVVAED | 376 | A6NGU5 | |
| HVGFDAVTGEFTPDL | 81 | O75914 | |
| EETVNDPEEAGHRSG | 541 | O00567 | |
| AEEELSARDGDPTFH | 1431 | Q14667 | |
| ESRAPETGEEHGSSQ | 226 | Q6DN14 | |
| HDETLPGGSESEATA | 1086 | P46821 | |
| AEVGSPHSTEVDDSL | 1576 | P46821 | |
| HFEEQSVPGEASDGL | 171 | Q6DN12 | |
| DEPEDFVIATGEVHS | 266 | O60547 | |
| HVDSEAPREEESSGF | 611 | Q6ZRS4 | |
| FGGSEENTPLDLDDH | 1051 | Q14643 | |
| GHLDGDSKEVSPIFT | 386 | Q96EF0 | |
| TGTVHTDDGAVVSPD | 2351 | O95714 | |
| GNTHFEESFTDGPEK | 2951 | Q03001 | |
| THPELDTDGDGALSE | 236 | P14314 | |
| GTAGAEVEVSVHEFP | 1796 | Q8NDA2 | |
| AAIDVTHLEEADGGP | 21 | Q8N5S9 | |
| HGEREPFAETDEHTG | 36 | Q8IZU0 | |
| TFVRSTPDGTEHGEF | 66 | P52789 | |
| PAETDITETSINGHG | 406 | P12107 | |
| GEDGVSFIHPSSELF | 346 | P29376 | |
| LPGDSGVEFTHDESV | 151 | Q9UK22 | |
| EPTHFTVDCTEAGEG | 761 | O75369 | |
| RSEEDGLAEAPEHGT | 46 | Q8NBP7 | |
| EAGSDSSGEEHVLAP | 51 | P23409 | |
| LEEHGPGQTVSEEAT | 116 | Q9UHL3 | |
| DTSDTSPEDGVYIHG | 2981 | Q6ZR08 | |
| SVDFHLDGISSDECP | 221 | O60928 | |
| RGAEEAFPAETLGHT | 1181 | P48681 | |
| EGDIHENVDTDLPGS | 101 | Q9UK76 | |
| FNHELTDVTSGPEVE | 656 | O94854 | |
| GVSAHTDSVPISEEG | 1341 | O94854 | |
| DVPFEETVVDGVHGA | 591 | Q9UL01 | |
| EVPHGQESDLFSETS | 1156 | O95163 | |
| TGPEEEATVHDGSEE | 866 | Q92887 | |
| REFELTAHISDGGTP | 531 | Q9UN70 | |
| TLEEHSSGTPEAGVA | 121 | Q6UWI2 | |
| GGEDTEESDSPDSHL | 366 | P78316 | |
| STPHGTEQGDFVVLE | 81 | P52790 | |
| LEHSDLPDGTGEFLD | 1186 | Q7Z6Z7 | |
| SSEPFGHLVDDDDIS | 306 | Q53HC9 | |
| TPDDGGTAHLSVVAE | 31 | B5MD39 | |
| DGRTTEDHITADPGT | 91 | E2RYF7 | |
| EDHITADPGTTEDSV | 96 | E2RYF7 | |
| AFEVQPISTEVHEGG | 136 | Q2VWP7 | |
| LHISDDVFGESGPDS | 26 | Q8N414 | |
| LGEDVIFHPEGEFDS | 26 | Q9UKF2 | |
| FESVHGTAPDIAGKD | 286 | P50213 | |
| GGTEASVEVLFEPSH | 4981 | Q4G0P3 | |
| ELGPDGEFHASSKVF | 336 | Q96M94 | |
| SHASDPTTDDIFEEG | 531 | O75553 | |
| STATSEHVVPSEGED | 771 | Q8N3K9 | |
| EHVVPSEGEDLGSER | 776 | Q8N3K9 | |
| FSHDSIFIPDGGAES | 6 | Q6ZU35 | |
| IDSSEGVRPDGFAHI | 1441 | P12111 | |
| GEFVDDGTETHFSIG | 131 | Q9NVQ4 | |
| PTVVAGFDLVGHEDT | 316 | Q9NZK5 | |
| HELGPQEEESTGVSF | 216 | O15033 | |
| HRSAGEEEDGPVLTD | 146 | Q66PJ3 | |
| PSSDVFDHSPIDGLE | 3061 | Q12955 | |
| VHSDSETDDIGFIPS | 476 | P78352 | |
| GSSLSDAVHVEFSPD | 86 | Q96P31 | |
| DTPETDDSIEGHGAS | 486 | Q6P0Q8 | |
| EGHFDISTDPETNEG | 321 | Q8IXH8 | |
| EFIPKNSHVGSDGSE | 331 | P32314 | |
| VGPSHEEEDTFSSVF | 186 | Q8NA03 | |
| GFTHRGSEPEEEEDV | 66 | P05111 | |
| AEHTSPEESRVLGFG | 256 | Q8N7W2 | |
| GSEHTVDGKSFPSEL | 106 | P43166 | |
| LSGDFTPITQGHTDE | 531 | O00423 | |
| EATGDDHLPFTSVGS | 1251 | Q9Y4K1 | |
| TPENGSEDIFVHVSD | 86 | Q9Y534 | |
| TLEGVHSVDGDPITD | 326 | P39059 | |
| DFVVGSFTHLDPEHG | 196 | A0AV02 | |
| APHRSTVEEDNDSGG | 581 | Q9BXL7 | |
| GDDGDHFTITTHPES | 371 | P22223 | |
| HSTLVNEEEDPSGGR | 56 | Q56UN5 | |
| HSSSEDEDIEGAFPN | 541 | O75170 | |
| PDDGGTAHLSVVAED | 376 | P36268 | |
| HFNGDFGDEVTSIPD | 1066 | Q13615 | |
| DGTEEDNSRVEPVGH | 241 | Q8TEW0 | |
| EDLPTSSETFGLHVE | 231 | A8MW92 | |
| CEAEGAHLTSVPFGE | 91 | Q6ZN16 | |
| HGLAQGSSEEEELPS | 746 | Q8IVF1 | |
| HGLAQGSSEEEELPS | 746 | A6NNL0 | |
| HGLAQGSSEEEELPS | 746 | B1AL46 | |
| LVEDGIPEFSHETAD | 2251 | P11717 | |
| EGETQGVAFEHESPA | 341 | P78332 | |
| DEDTHSSFPDGEQIG | 936 | O94972 | |
| GVDPTEHLFENGSEF | 186 | Q5TGL8 | |
| ETTGATENGHEAVPE | 11 | Q99729 | |
| LQDDDDTVHLPFEGG | 1161 | Q9Y6M7 | |
| HGSIFGDINSSPSED | 131 | Q6P5X7 | |
| SEDSRGTFVPDILHG | 2041 | Q8WUY3 | |
| VPGEDGIETHFDELQ | 326 | Q13275 | |
| SVTDEDGPETHFDEL | 291 | Q99985 | |
| VTIHECDEGSEPLGF | 1961 | O95425 | |
| GHDVDFLITSPGSTE | 341 | P04053 | |
| GESFVGDHERTPNDF | 531 | Q6T4R5 | |
| LQATSEDVHGFEAPG | 966 | Q5VVP1 | |
| EDVHGFEAPGTSKSS | 971 | Q5VVP1 | |
| TLVSSSADPEGHFET | 871 | Q14697 | |
| DEVFEFPGVTAGHRD | 571 | Q8IV61 | |
| PESLHQLFEGESETE | 1381 | Q7Z3K3 | |
| VESSIPHTDSGIGEE | 1666 | Q8NFP9 | |
| QATSEDVHGFEAPGT | 971 | Q8IWB4 | |
| SESTVHIGVGEPDFI | 1586 | Q96Q15 | |
| IEFLEGAEGVDHPSH | 2516 | Q96Q15 | |
| PDHSEFADLRSGVTG | 151 | Q6P050 | |
| EESFSEHLGFTGGIV | 1056 | P51532 | |
| AHGLAPDGDVFLSEE | 196 | Q9Y6E7 | |
| SHRGEGEEDHESPSS | 261 | Q9NTX7 | |
| VTGGEIASTFDHPEL | 326 | P78371 | |
| TVHTDDGAVVSPDLG | 1066 | Q9BVR0 | |
| DSEQEAHSGGEPTFA | 416 | Q92502 | |
| EPTFASSLSVEEGHS | 426 | Q92502 | |
| RVTGPEGALFEHSVE | 166 | Q13326 | |
| EERHSASECPEGGSE | 11 | Q9Y566 | |
| DRTEDDGPLETHGHS | 76 | O60284 | |
| DGPLETHGHSTAEEI | 81 | O60284 | |
| LDDHFRESEEPATSG | 301 | Q969K4 | |
| REPTTHAEAQGDEGD | 541 | Q8IVF2 | |
| ESIDHSVTGFLCEPD | 351 | Q9H553 | |
| EPSLESGVHSFEEGS | 251 | Q9HAW4 | |
| TVQPSGVEEDFHIGE | 281 | O43298 | |
| QTPLTEGSEDLDGHS | 306 | Q86VR2 | |
| LVHEEGEPEAASAGS | 141 | Q96CW6 | |
| QATSEDVHGFEAPGT | 971 | Q5VYP0 | |
| DSSFSEDEHLPRGGA | 2126 | O15417 | |
| DIHFTLDSGPEGASV | 1126 | Q8N2E2 | |
| SVVFESDGPRGSEVH | 1121 | Q92618 | |
| EHGSPVSEDNFEEGS | 501 | Q9ULJ3 | |
| DTDEVFRGHEPGQAA | 931 | Q9C0E2 | |
| SPGEDHGEVVSQDRE | 191 | Q7Z7L9 | |
| TVPHDEDSSDDIAVG | 21 | Q70EL2 | |
| THPVEDGIFDSGNFE | 21 | Q6P5R6 | |
| LEDISADPEDTVGGH | 116 | Q86YL5 | |
| THSSIADLEEGEPAE | 831 | Q76I76 | |
| SEPGAIDEVDHDNGT | 721 | O43295 | |
| TFGPHASIEEEARED | 431 | Q96MK2 | |
| QATSEDVHGFEAPGT | 971 | Q5VU36 | |
| EGAHGLREEPEFVTA | 21 | Q9UPX0 | |
| GLSESEAEPDGDHNI | 236 | Q9NQ55 | |
| LVCSVPGVEGDTHFD | 291 | Q13214 | |
| SPEGVESQDGVDHFR | 716 | P38935 | |
| PEGDDFLSLHAESDG | 441 | Q9H7N4 | |
| DGSSHIAGDLPSDED | 146 | Q99592 | |
| AGSIDGTDEDPHDRA | 16 | Q16560 | |
| DTEHENTETDHPGGL | 156 | Q6N022 | |
| TEGGEEHVFENSPVL | 286 | O94885 | |
| EEEETGENHTIFIGP | 636 | Q9GZR1 | |
| EDGSEAATSTGIHIP | 341 | O75830 | |
| ELVEGGHPSSDEVRS | 946 | Q9H254 | |
| LPELEAHGVSESEGE | 396 | Q9BVJ6 | |
| AHGVSESEGEERPVA | 401 | Q9BVJ6 | |
| PEDVGLDASTAESFH | 1821 | P11277 | |
| EQTFHTPSLGDEEFE | 51 | O15405 | |
| GGTVDIVESEPENDH | 266 | P17010 | |
| EEEVGEEPVSTSHFS | 1636 | Q96JM2 | |
| PVENSVAEFDSHSGG | 636 | Q6ZSB9 | |
| HTRSGSEEAVTDPGE | 1616 | Q92508 | |
| NEVEPDDDHFSIGVG | 236 | Q15633 | |
| HPELEGTAVSGEEAE | 456 | Q5QJ38 | |
| SEIEFHEIIGSGSFG | 461 | Q59H18 | |
| GEIITDRPGFHDESA | 196 | Q3YBR2 | |
| LSGAETFHTPSLGDE | 21 | O94842 | |
| SEDPVVGHLGTSTEE | 226 | Q9UBP6 | |
| PDDGGTAHLSVVAED | 376 | P19440 | |
| TDHGSTGILVFPNED | 146 | Q99538 |